Apontis Pharma’s €101 Million Initial Public Offering

McDermott Will & Emery acted as Transaction Counsel for the issuer, its main shareholder Paragon Partners as well as the Joint Bookrunners Hauck & Aufhäuser and…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here